CXI Healthcare Technology Group Limited Stock

Equities

A900120

KYG2114A1094

Food Processing

End-of-day quote Korea S.E. 06:00:00 2024-05-27 pm EDT 5-day change 1st Jan Change
115 KRW +6.48% Intraday chart for CXI Healthcare Technology Group Limited +7.48% -2.54%
Sales 2022 101B 74.31M Sales 2023 71.62B 52.5M Capitalization 26.54B 19.45M
Net income 2022 5.98B 4.38M Net income 2023 7.53B 5.52M EV / Sales 2022 -0.33 x
Net cash position 2022 65.4B 47.94M Net cash position 2023 93.66B 68.65M EV / Sales 2023 -0.94 x
P/E ratio 2022
5.33 x
P/E ratio 2023
3.45 x
Employees 10
Yield 2022 *
-
Yield 2023
-
Free-Float 78.63%
More Fundamentals * Assessed data
Dynamic Chart
CXI Healthcare Technology Group Limited Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
CXI Healthcare Technology Group Limited announced that it has received KRW 4.602899736 billion in funding CI
CKH Food & Health Limited announced that it has received KRW 7.432995165 billion in funding CI
CKH Food & Health Limited announced that it expects to receive KRW 4.602899736 billion in funding CI
CKH Food & Health Limited announced that it expects to receive KRW 7.432995165 billion in funding CI
An unknown buyer completed the acquisition of 60% stake in Shenzhen Jinpa Yeosa Biological Technology Co., Ltd. from CXI Healthcare Technology Group Limited. CI
An unknown buyer completed the acquisition of 70% stake in Beijing Huashundang Biological Technology Co., Ltd. from CXI Healthcare Technology Group Limited. CI
An unknown buyer completed the acquisition of Geumparyeosa Biological Technology Co., Ltd. from CXI Healthcare Technology Group Limited CI
CKH Food & Health Limited announced that it has received KRW 4.875514218 billion in funding from Below Investment Co., Ltd. CI
CKH Food & Health Limited announced that it expects to receive KRW 4.875514218 billion in funding from Below Investment Co., Ltd. and other investors CI
CKH Food & Health Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
CKH Food & Health Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
CKH Food & Health Limited Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
CKH Food & Health Limited announced that it has received KRW 10.911791808 billion in funding from Rui Xing International Holdings Limited CI
CKH Food & Health Limited announced that it expects to receive KRW 10.911791808 billion in funding from Rui Xing International Holdings Limited, and other investors CI
More news
1 day+6.48%
1 week+7.48%
Current month+4.55%
1 month+6.48%
3 months-9.45%
6 months+2.68%
Current year-2.54%
More quotes
1 week
103.00
Extreme 103
127.00
1 month
103.00
Extreme 103
127.00
Current year
103.00
Extreme 103
154.00
1 year
103.00
Extreme 103
203.00
3 years
103.00
Extreme 103
445.00
5 years
103.00
Extreme 103
579.00
10 years
103.00
Extreme 103
5 523.81
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 11-04-30
Director/Board Member 60 13-02-28
Comptroller/Controller/Auditor 46 14-10-15
Members of the board TitleAgeSince
Director/Board Member 60 13-02-28
Chief Executive Officer 61 11-04-30
Director/Board Member 59 09-09-23
More insiders
Date Price Change Volume
24-05-28 115 +6.48% 43,373,810
24-05-27 108 +3.85% 1,559,521
24-05-24 104 -0.95% 531,113
24-05-23 105 0.00% 761,428
24-05-22 105 -1.87% 1,358,861

End-of-day quote Korea S.E., May 27, 2024

More quotes
CKH Food & Health Limited is a Cayman Islands-based health food manufacturing and distribution company. The Company is engaged in the production of health supplements, functional health foods, and tea products. The Company is specialized in the production of various types of products such as tablets, capsules, granules, drinks, and tea. The Company’s products include traditional Chinese medicine-based dietary supplements (capsules/tablets/drinks/tea). The Company’s products include Kimparis Ellabie HA Waterful Sunscreen, Kimparis Ellabie PDR Serum, Pterygium capsule, Raw Steel Capsule and more.
More about the company
  1. Stock Market
  2. Equities
  3. A900120 Stock